Dosing of Mefenamic Acid
For adults and adolescents ≥14 years, mefenamic acid should be dosed at 500 mg initially, followed by 250 mg every 6 hours as needed. 1
Standard Dosing Regimens
Acute Pain Management
- Initial dose: 500 mg
- Maintenance: 250 mg every 6 hours
- Duration: Usually not to exceed one week 1
- Time to onset: Approximately 30 minutes 2, 3, 4
Primary Dysmenorrhea
- Initial dose: 500 mg at onset of bleeding or pain
- Maintenance: 250 mg every 6 hours
- Duration: Typically 2-3 days (should not be necessary for more than this) 1
- Clinical trials demonstrate effective treatment when initiated at the start of menses 1
Maximum Daily Dose
The maximum daily dose is 2000 mg (4 × 500 mg) across all indications 2, 3, 4, 5, 6, 4
Important Clinical Considerations
Pediatric Use
Mefenamic acid has not been adequately studied in children <14 years of age 1. The FDA label explicitly states dosing is only established for adolescents ≥14 years and adults. While recent observational data 7 suggests 5 mg/kg three times daily may be used in children ≥6 months, this remains off-label and requires careful consideration given limited safety data 8.
Pharmacokinetic Profile
- Peak plasma levels: Reached in 2-4 hours 1
- Half-life: Approximately 2 hours 1
- Protein binding: >90% bound to albumin 1
- Metabolism: Via CYP2C9 to active metabolites 1
Duration of Therapy
Mefenamic acid should be used at the lowest effective dose for the shortest duration consistent with treatment goals 1. This is critical because:
- Prolonged use increases gastrointestinal and renal toxicity risk
- The drug is designed for short-term symptomatic relief (typically ≤7 days for pain, 2-3 days for dysmenorrhea)
Special Populations Requiring Dose Adjustment
Renal impairment: Mefenamic acid should not be administered to patients with pre-existing renal disease or significantly impaired renal function 1. Both the parent drug and metabolites are primarily renally excreted, creating accumulation risk.
Hepatic impairment: Reduced doses may be necessary as hepatic metabolism is a significant elimination pathway 1. However, specific dosing recommendations are not established—use with extreme caution or avoid.
Elderly patients: While no specific dose reduction is mandated by age alone, increased vigilance is warranted due to age-related decline in renal function and higher risk of adverse effects.
Common Pitfalls to Avoid
- Exceeding 2000 mg daily dose: This increases toxicity without additional benefit
- Prolonged use beyond one week for pain: Increases GI bleeding, ulceration, and renal toxicity risk
- Use in patients with renal disease: Contraindicated due to accumulation risk and nephrotoxicity 1
- Combining with other NSAIDs: Increases adverse event risk without improving efficacy
- Ignoring GI protection: When used for >3-5 days, consider gastroprotection, particularly in high-risk patients 3
Administration Timing
Mefenamic acid can be taken with or without food, though the FDA label notes that antacids containing magnesium hydroxide significantly increase absorption rate and extent 1. For dysmenorrhea, initiate at the first sign of bleeding or pain for optimal efficacy 1.